Skip to main content
. 2010 Nov 17;28(35):5166–5173. doi: 10.1200/JCO.2010.29.7010

Fig A3.

Fig A3.

Paroxysmal nocturnal hemoglobinuria (PNH) clone sizes in patients treated with alemtuzumab. Percentage of glycosylphosphatidylinositol (GPI) -linked anchored protein expression in peripheral blood neutrophils was determined by flow cytometry at 0, 3, 6, and 12 months after alemtuzumab treatment. Each line represents an individual patient.